A. Martinez

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

M. Lederman, D. Kuritzkes, J. Leonard, 1998, The Journal of infectious diseases.

A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

M A Fischl, J. Phair, M. Hirsch, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

HCV RNA decline in the first 24 h exhibits high negative predictive value of sustained virologic response in HIV/HCV genotype 1 co-infected patients treated with peginterferon and ribavirin.

H. Salomón, P. Cahn, A. Martínez, 2011, Antiviral research.

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.

M. Lederman, D. Kuritzkes, J. Leonard, 2000, The Journal of infectious diseases.

Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

B. Gallagher, W. El-Sadr, A. Martínez, 2000, The New England journal of medicine.

Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain

C. Touron, I. Oyagüez, E. Martínez-Moragón, 2022, The Journal of asthma : official journal of the Association for the Care of Asthma.